Nutra Pharma Corp. (NPHC)

Market Cap	709.97K
Revenue (ttm)	438.27K
Net Income (ttm)	8.18M
Shares Out	7.10B
EPS (ttm)	0.00
PE Ratio	0.25
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,550
Average Volume	714,934
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	33.93
RSI	43.43
Earnings Date	Nov 21, 2025

About Nutra Pharma

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. It offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: NPHC